January 3, 2018—Pharmaceutical manufacturers dramatically increased their worldwide revenue between 2006 and 2015, with total drug sales jumping 45 percent, from $534 billion to $775 billion in 2015 dollars, according to a new report by the federal government’s chief oversight agency. The Government Accountability Office (GAO) found two-thirds (67 percent) of drug makers saw an increase in their annual profit margins, with average yearly profits jumping between 15 and 20 percent for the largest 25 manufacturers – well above the average 4 to 9 percent margins for the largest non-drug companies. The average annual profit margin for all drug makers between 2006 and 2015 was 17.1 percent, GAO said.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)